Medicare Enrolled

Dr. Maurice McCarthy, MD

Rheumatology · Winter Haven, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
635 1ST ST N, Winter Haven, FL 33881
8632940670
In practice since 2006 (20 years)
NPI: 1346219870 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McCarthy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McCarthy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McCarthy

Dr. Maurice McCarthy is a rheumatology in Winter Haven, FL, with 20 years in practice. Based on federal Medicare data, Dr. McCarthy performed 106,429 Medicare services across 4,834 unique beneficiaries.

Between the years covered by Open Payments, Dr. McCarthy received a total of $12,076 from 35 pharmaceutical and/or device companies across 647 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McCarthy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 24% volume in FL$ $12,076 industry payments

Medicare Practice Summary

Medicare Utilization ↗
106,429
Medicare services
Top 24% in FL for rheumatology
4,834
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,321 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)55,600$4$16
Golimumab infusion (Simponi Aria)11,400$10$48
Abatacept infusion (Orencia)9,875$33$69
Denosumab injection (Prolia/Xgeva)9,840$18$42
Infliximab infusion (Remicade)8,940$26$152
Methotrexate sodium, 5 mg1,285$0$2
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle741$55$121
Office visit, established patient (30-39 min)600$93$243
Blood draw (venipuncture)529$8$10
Sed rate test (inflammation marker)499$3$15
Complete blood count (CBC) with differential496$8$25
Liver function blood test panel492$8$24
C-reactive protein test (inflammation marker)484$5$15
Basic metabolic blood panel480$8$25
Glutamyltransferase (liver enzyme) level479$7$20
Uric acid level test477$4$18
Drug injection, under skin or into muscle359$11$33
Injection, ketorolac tromethamine, per 15 mg355$0$10
Administration of chemotherapy into vein, 1 hour or less295$99$303
Betamethasone steroid injection251$5$9
Administration of chemotherapy into vein, each additional hour245$22$70
Measurement of antibody for assessment of autoimmune disorder, any method200$17$48
Vitamin D level test158$29$85
Rheumatoid factor level157$6$26
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less150$49$139
Free thyroxine (T4) test145$9$30
Thyroid stimulating hormone (TSH) test145$16$53
Thyroid hormone, t3 measurement, total141$14$40
Lipid panel (cholesterol and triglycerides)140$13$38
Office visit, established patient, complex (40-54 min)124$120$347
Screening test for autoimmune disorder121$12$35
Vitamin B-12 level test94$15$60
Bone density scan (DEXA)82$37$98
Chest X-ray, 2 views71$24$65
Flu vaccine administration71$29$31
Flu vaccine, high-dose70$72$117
Parathyroid hormone level test65$40$115
Urinalysis with microscopic exam59$3$15
Administration of chemotherapy into vein using push technique56$78$225
Pneumonia vaccine administration56$29$31
Ferritin level test (iron stores)47$13$40
Measurement of dna antibody, native or double stranded40$13$37
Folic acid level test36$14$60
Iron binding capacity test35$9$24
Injection, methylprednisolone acetate, 80 mg35$9$15
Iron level test34$7$18
Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use33$280$375
Blood creatinine level31$5$24
X-ray of wrist, minimum of 3 views30$30$50
Blood glucose (sugar) level29$4$15
X-ray of hand, minimum of 3 views26$28$52
Pneumococcal vaccine, 23-valent26$131$228
Blood test panel for electrolytes (sodium potassium, chloride, carbon dioxide)24$7$20
Calcium level, total23$5$18
Urea nitrogen level to assess kidney function, quantitative23$4$11
Urine culture, bacterial colony count23$8$24
Red blood count, automated test21$4$12
Hip X-ray, 2-3 views15$34$80
Hepatitis c antibody measurement14$14$40
Magnesium level test12$6$25
Measurement of antibody for rheumatoid arthritis assessment12$13$35
X-ray of upper spine, 6 or more views11$35$111
Bacterial culture, aerobic11$8$25
Antibiotic sensitivity test11$8$25
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
28.5% high complexity
63.7% medium
7.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$12,076
Total received (2018-2024)
Avg $1,725/year across 7 years
Top 38% in FL for rheumatology
35
Companies
647
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,665 (96.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$411 (3.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,027
2023
$1,555
2022
$1,796
2021
$1,495
2020
$961
2019
$2,344
2018
$2,898

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$2,031
Janssen Biotech, Inc.
$1,469
Novartis Pharmaceuticals Corporation
$1,298
PFIZER INC.
$1,080
GlaxoSmithKline, LLC.
$1,024
UCB, Inc.
$967
E.R. Squibb & Sons, L.L.C.
$513
AbbVie, Inc.
$501
AstraZeneca Pharmaceuticals LP
$470
Genentech USA, Inc.
$368
GENZYME CORPORATION
$347
Radius Health, Inc.
$317
AbbVie Inc.
$300
Janssen Scientific Affairs, LLC
$241
ABBVIE INC.
$169
Janssen Pharmaceuticals, Inc
$158
Novo Nordisk Inc
$122
Celgene Corporation
$120
Lilly USA, LLC
$103
Ferring Pharmaceuticals Inc.
$61
Abbott Laboratories
$48
Sobi, Inc
$38
Takeda Pharmaceuticals U.S.A., Inc.
$38
Antares Pharma, Inc.
$34
Horizon Therapeutics plc
$33
Ironwood Pharmaceuticals, Inc
$30
Merck Sharp & Dohme Corporation
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$28
Biohaven Pharmaceuticals, Inc.
$27
Esperion Therapeutics, Inc.
$25
MEDEXUS PHARMA, INC.
$24
Horizon Pharma plc
$21
Merck Sharp & Dohme LLC
$21
Eisai Inc.
$14
MEDAC PHARMA, INC.
$11
Top 3 companies account for 39.7% of total payments
Associated products mentioned in payments ›
Actemra · Amitiza · BELSOMRA · BENLYSTA · COSENTYX · CYLTEZO · Cimzia · DUZALLO · Dayvigo · EUFLEXXA · EVENITY · Enbrel · FARXIGA · FREESTYLE LIBRE 3 · GARDASIL 9 · HUMIRA · Humira · INFLECTRA · KEVZARA · KRYSTEXXA · Kineret · LEQVIO · LINZESS · NEXLETOL · NURTEC ODT · ORENCIA · Otezla · Otrexup · Ozempic · PENNSAID · Prolia · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · Rybelsus · SAPHNELO · SIMPONI ARIA · SKYRIZI · TALTZ · TREMFYA · Tymlos · Uloric · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $11 per 100 Medicare services performed
Looking for a rheumatology in Winter Haven?
Compare rheumatologys in the Winter Haven area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
15
Per 100K population
2.0
County median income
$63,644
Nearest hospital
WINTER HAVEN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. McCarthy is a mixed practice specialist, with above-average Medicare volume (top 24% in FL), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. McCarthy experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. McCarthy performed 55,600 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McCarthy receive payments from pharmaceutical companies?
Yes. Dr. McCarthy received a total of $12,076 from 35 companies across 647 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McCarthy's costs compare to other rheumatologys in Winter Haven?
Dr. McCarthy's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McCarthy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →